Answers are grounded in this paper and cite their sources.
OBJECTIVE: To evaluate the real-world implementation, screening performance, aspirin uptake, and safety of a FIGO (the International Federation of Gynecology & Obstetrics)-based first-trimester pre-eclampsia screening and prevention program. METHODS: This retrospective cohort study included women initiating antenatal care before 14 weeks of gestation at a tertiary referral center in southern Thailand from 2021 to 2024. Screening incorporated maternal factors, mean arterial pressure, and uterine artery pulsatility index. Women with a calculated risk of 1:100 or greater were classified as being at high risk and offered aspirin 162 mg nightly. Outcomes included screening coverage, detection rates, aspirin uptake, pregnancy outcomes, and bleeding complications. RESULTS: Among 1713 pregnancies, 71 developed pre-eclampsia (4.1%), including 49 with severe features. Overall, 1106 women were screened (64.6%), but coverage reached 93.6% by the end of implementation. The screen-positive rate was 11.3%. Detection rates were 61.7% for overall pre-eclampsia, 69.6% for delivery before 37 weeks of gestation, 87.5% for delivery before 34 weeks of gestation, and 100% for delivery before 32 weeks of gestation, with false-positive rates of approximately 9%-11%. Aspirin uptake among screen-positive women was 99.2%. Pre-eclampsia was associated with higher rates of cesarean delivery, preterm birth, lower birth weight, and neonatal intensive care unit admission. No eclampsia, placental abruption, maternal intensive care unit admission, maternal death, stillbirth, or neonatal death occurred. After adjustment for potential confounders, aspirin was not associated with the risk of an estimated blood loss of 500 mL or more, and the risk of an estimated blood loss of 1000 mL or more did not differ significantly between groups. CONCLUSION: FIGO-based first-trimester screening was feasible in routine care, with increasing coverage as implementation matured, near-universal aspirin uptake, and clinically useful detection of preterm pre-eclampsia. Aspirin use was not significantly associated with severe bleeding.
No takes yet. Share an insight, caveat, or question.
Sophark et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: